American Century Companies Inc. Reduces Stock Holdings in Bruker Corporation $BRKR

American Century Companies Inc. cut its stake in shares of Bruker Corporation (NASDAQ:BRKR) by 5.9% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 27,257 shares of the medical research company’s stock after selling 1,714 shares during the period. American Century Companies Inc.’s holdings in Bruker were worth $1,138,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Teacher Retirement System of Texas boosted its stake in shares of Bruker by 5.1% in the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company’s stock valued at $1,212,000 after purchasing an additional 1,422 shares during the period. Fifth Third Bancorp lifted its holdings in Bruker by 54.2% in the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company’s stock worth $46,000 after buying an additional 390 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Bruker by 81.2% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company’s stock valued at $1,245,000 after buying an additional 13,367 shares during the last quarter. OneDigital Investment Advisors LLC grew its stake in shares of Bruker by 38.0% during the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company’s stock valued at $230,000 after acquiring an additional 1,520 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of Bruker by 45.8% during the first quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company’s stock valued at $55,000 after acquiring an additional 416 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Insider Buying and Selling at Bruker

In related news, CEO Frank H. Laukien purchased 2,608 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The shares were acquired at an average price of $38.36 per share, with a total value of $100,042.88. Following the acquisition, the chief executive officer owned 38,462,171 shares in the company, valued at approximately $1,475,408,879.56. This trade represents a 0.01% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 27.30% of the company’s stock.

Bruker Stock Performance

Bruker stock opened at $29.35 on Thursday. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70. Bruker Corporation has a 12 month low of $28.53 and a 12 month high of $72.94. The company has a fifty day moving average price of $37.59 and a two-hundred day moving average price of $39.96. The company has a market cap of $4.45 billion, a PE ratio of 56.44, a P/E/G ratio of 2.79 and a beta of 1.21.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business had revenue of $797.40 million during the quarter, compared to the consensus estimate of $811.17 million. During the same quarter in the previous year, the business posted $0.52 earnings per share. The company’s quarterly revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Research analysts expect that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 23rd. Bruker’s dividend payout ratio is presently 38.46%.

Analysts Set New Price Targets

A number of research analysts recently commented on BRKR shares. UBS Group reduced their price target on Bruker from $57.00 to $45.00 and set a “neutral” rating for the company in a report on Thursday, May 8th. Wells Fargo & Company cut their target price on Bruker from $60.00 to $50.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 5th. Bank of America reduced their target price on Bruker from $61.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. The Goldman Sachs Group dropped their price target on shares of Bruker from $50.00 to $45.00 and set a “neutral” rating for the company in a research note on Thursday, May 8th. Finally, Citigroup cut their price target on shares of Bruker from $40.00 to $38.00 and set a “neutral” rating on the stock in a report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $51.30.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.